Risk of Scar in the Comparison of Age-related Macular Degeneration Treatments Trials

OBJECTIVE: To describe risk factors for scar in eyes treated with ranibizumab or bevacizumab for neovascular age-related macular degeneration (AMD). DESIGN: Prospective cohort study within a randomized clinical trial. PARTICIPANTS: Patients with no scar on color fundus photography (CFP) or fluoresce...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Daniel, Ebenezer, Toth, Cynthia A., Grunwald, Juan E., Jaffe, Glenn J., Martin, Daniel F., Fine, Stuart L., Huang, Jiayan, Ying, Gui-shuang, Hagstrom, Stephanie A., Winter, Katrina, Maguire, Maureen G.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3943618/
https://ncbi.nlm.nih.gov/pubmed/24314839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2013.10.019
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars